Effects of microinjection of angiotensin II and captopril into nucleus accumbens on morphine self-administration in rats

Indian Journal of Experimental Biology

Volumn 47, Issue 5, 2009, Pages 361-367

  Hosseini, Mahmoud ^a   Alaei, Hojjat Allah ^b   Headari, Rahelah ^c   Eslamizadeh, Mohammad Javad ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KHARAZMI UNIVERSITY   (Iran)

Author keywords

Angiotensin II; Captopril; Morphine; NAC; Self administration

Indexed keywords

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ANGIOTENSIN II; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MORPHINE;

ANIMAL; ARTICLE; DRUG SELF ADMINISTRATION; MALE; MICROINJECTION; NUCLEUS ACCUMBENS; RAT; WISTAR RAT;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAPTOPRIL; MALE; MICROINJECTIONS; MORPHINE; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; SELF ADMINISTRATION;

EID: 67651018171     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. (Pubitemid 29106063) Diana M, Muntoni A L and Pistis M, Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal, Eur J Neurosci, 11 (1999) 1037.
2. Wang H L, Zhao Y and Xiang X H, Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats, Prog Neuropsychopharmacol Biol Psychiatry, 28 (2004) 1079.
3. Winnicka M M, Dopaminergic projection to the nucleus accumbens mediates the memory-enhancing effect of angiotensins in rats, Pharmacol Biochem Behav, 62 (1999) 625.
4. (Pubitemid 28167789) Winnicka M M, Braszko J J and Wisniewski K, 6-OHDA lesions to amygdala and hippocampus attenuate memoryenhancing effect of the 3-7 fragment of angiotensin II, Gen Pharmacol, 30 (1998) 801.
5. (Pubitemid 29292437) Winnicka M M and Wisniewski K, Disruption of temporoentorhinal connections abolishes the facilitatory effect of angiotensins on memory in rats, Pharmacol Res, 40 (1999) 53.
6. Allen A M, MacGregor D P and McKinley M J, Angiotensin II receptors in the human brain, Regul Pept, 79 (1999) 1.
7. Fischer-Ferraro C, Nahmod V E and Goldstein D J, Angiotensin and renin in rat and dog brain, J Exp Med, 133 (1971) 353.
8. Ganten D, Minnich J L and Granger P, Angiotensin-forming enzyme in brain tissue, Science, 173 (1971) 64.
9. (Pubitemid 23251954) Wright J W, Miller-Wing A V, Shaffer M J, Higginson C, Wright D E, Hanesworth J M and Harding J W, Angiotensin II (3-8) (ANG IV) hippocampal binding: Potential role in the facilitation of memory, Brain Res Bull, 32 (1993) 497.
10. Han N L, Luo F and Bian Z P, Synergistic effect of cholecystokinin octapeptide and angiotensin II in reversal of morphine induced analgesia in rats, Pain, 85 (2000) 465.
11. (Pubitemid 36258367) Tchekalarova J, Pechlivanova D and Kambourova T, The effects of sarmesin, an Angiotensin II analogue on seizure susceptibility, memory retention and nociception, Regul Pept, 111 (2003) 191.
12. (Pubitemid 27301383) Toma N, Sgambato V and Couture R, Effect of angiotensin II on a spinal nociceptive reflex in the rat: Receptor and mechanism of action, Life Sci, 61 (1997) 503.
13. Jenkins T A, Chai S Y and Mendelsohn F A, Upregulation of angiotensin II AT1 receptors in the mouse nucleus accumbens by chronic haloperidol treatment, Brain Res, 748 (1997) 137.
14. Reardon K A, Mendelsohn F A and Chai S Y, The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson's disease, Aust N Z J Med, 30 (2000) 48.
15. Nikolova J G, Getova D P and Nikolov F P, Effects of ACE-inhibitors on learning and memory processes in rats, Folia Med (Plovdiv), 42 (2000) 47.
16. (Pubitemid 32382318) Raghavendra V, Chopra K and Kulkarni S K, Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm, Neuropeptides, 35 (2001) 65.
17. Giardina W J and Ebert D M, Positive effects of captopril in the behavioral despair swim test, Biol Psychiatry, 25 (1989) 697.
18. (Pubitemid 20134208) Martin P, Massol J and Puech A J, Captopril as an antidepressant? Effects on the learned helplessness paradigm in rats, Biol Psychiatry, 27 (1990) 968.
19. (Pubitemid 30813411) Margolin A, Avants S K and Setaro J F, Cocaine, HIV, and their cardiovascular effects: Is there a role for ACE-inhibitor therapy?, Drug Alcohol Depend, 61 (2000) 35.
20. Hosseini M, Sharifi M R and Alaei H, Effects of angiotensin II and captopril on rewarding properties of morphine, Indian J Exp Biol, 45 (2007) 770.
21. (Pubitemid 46636228) Alaei H and Hosseini M, Angiotensin converting enzyme inhibitor captopril modifies conditioned place preference induced by morphine and morphine withdrawal signs in rats, Pathophysiology, 14 (2007) 55.
22. (Pubitemid 40980265) Alaei H, Esmaeili M and Nasimi A, Ascorbic acid decreases morphine self-administration and withdrawal symptoms in rats, Pathophysiology, 12 (2005) 103.
23. Sahraei H, Poorheidari G and Foadaddini M, Effects of nitric oxide on morphine self-administration in rat, Pharmacol Biochem Behav, 77 (2004) 111.
24. Sahraei H, Motamedi F and Khoshbaten A, Adenosine A (2) receptors inhibit morphine self-administration in rats, Eur J Pharmacol, 383 (1999) 107.
25. Paxinos G and Watson C, The rat brain in stereotaxic coordinates (4th ed.), (Academic Press, New York) 1998.
26. Kim S Y, Chudapongse N and Lee S M, Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains, Mol Brain Res, 133 (2005) 58.
27. (Pubitemid 41121973) Rajaei Z, Alaei H, Nasimi A, Amini H and Ahmadiani A, Ascorbate reduces morphine-induced extracellular DOPAC level in the nucleus accumbens: A microdialysis study in rats, Brain Research, 1053 (2005) 62.
28. Gupta Y K, Chugh A and Arora S, Modulation of morphine induced antinociception by intracerebroventricularly administered captopril, Indian J Exp Biol, 29 (1991) 543.
29. (Pubitemid 26364241) Takai S, Song K and Tanaka T, Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice, Life Sci, 59 (1996) 331.
30. (Pubitemid 17200350) Koyuncuoglu H, Gungor M and Enginar N, Brain asparaginase, ACE activity and plasma cortisol level in morphine dependent rats: Effect of aspartic acid and naloxone, Pharmacol Biochem Behav, 25 (1986) 953.
31. (Pubitemid 16210228) La J and Atkinson J, Involvement of the renin-angiotensin system in the dipsogenic effect of morphine, Arch Int Pharmacodyn Ther, 278 (1985) 273.
32. (Pubitemid 13223233) Das S, Chatterjee T K and Ghosh J J, Adrenal involvement in captopril-induced potentiation of morphine analgesia, Eur J Pharmacol, 85 (1982) 217.
33. (Pubitemid 36576949) Hikida T, Kitabatake Y and Pastan I, Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine, Proc Natl Acad Sci U S A, 100 (2003) 6169.
34. Koob G F, Sanna P P and Bloom F E, Neuroscience of addiction, Neuron, 21 (1998) 467.
35. Daubert D L, Meadows G G, Wang J H, Sanchez P J and Speth R C, Changes in angiotensin II receptors in dopaminerich regions of the mouse brain with age and ethanol consumption, Brain Res, 816 (1999) 8.
36. Jones D L, Central integration of cardiovascular and drinking responses elicited by central administration of angiotensin II: Divergence of regulation by the ventral tegmental area and nucleus accumbens, Can J Physiol Pharmacol, 64 (1986) 1011.
37. Jenkins T A, Chai S Y and Mendelsohn F A, Upregulation of angiotensin II AT1 receptors in the mouse nucleus accumbens by chronic haloperidol treatment, Brain Res, 748 (1997) 137.
38. (Pubitemid 39167358) Stragier B, Sarre S and Vanderheyden P, Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat, J Neurochem, 90 (2004) 1251.
39. Kulkosky P J, Allison T G and Carr B A, Angiotensin II reduces alcohol intake and choice in water- or food-restricted rats, Alcohol, 13 (1996) 359.
40. Blair-West J R, Denton D A, McBurnie M I and Weisinger R S, The dipsogen angiotensin II does not stimulate ethanol intake in mice, Physiol Behav, 60 (1996) 481.
41. Grupp L A and Harding S, Intracerebroventricularly infused angiotensin II or III do not alter voluntary alcohol intake in rats, Pharmacol Biochem Behav, 51 (1995) 593.
42. Fitts D A, Angiotensin and captopril increase alcohol intake, Pharmacol Biochem Behav, 45 (1993) 35.
43. (Pubitemid 24150555) Di Chiara G, Morelli M and Consolo S, Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions, Trends Neurosci, 17 (1994) 228.
44. Kawaguchi Y, Wilson C J and Augood S J, Striatal interneurones: Chemical, physiological and morphological characterization, Trends Neurosci, 18 (1995) 527.
45. Krall W J, Sramek J J and Cutler N R, Cholinesterase inhibitors: A therapeutic strategy for Alzheimer disease, Ann Pharmacother, 33 (1999) 441.
46. (Pubitemid 28509007) Hadjiivanova C H and Georgiev V, In vitro effect of angiotensin II on GABA release in rat hippocampus, Neuropeptides, 32 (1998) 431.
47. (Pubitemid 28500829) Tsuda K, Tsuda S and Nishio I, Captopril inhibits both dopaminergic and cholinergic neurotransmission in the central nervous system, Clin Exp Pharmacol Physiol, 25 (1998) 904.
48. Chai S Y, McKinley M J and Paxinos G, Angiotensin converting enzyme in the monkey (Macaca fascicularis) brain visualized by in vitro autoradiography, Neuroscience, 42 (1991) 483.
49. Chai S Y, McKenzie J S and McKinley M J, Angiotensin converting enzyme in the human basal forebrain and midbrain visualized by in vitro autoradiography, J Comp Neurol, 291 (1990) 179.